Aurelius Health Group Review
Best for: Buyers specifically seeking a transparent, care-inclusive compounded-tirzepatide MICRODOSING program who understand that microdosing has a more limited evidence base and likely smaller weight-loss effect than standard full-dose therapy. Not for buyers wanting maximum-efficacy full-dose GLP-1 treatment. Verify state availability, pharmacy sourcing, and clinical oversight directly.
Aurelius Health Group (aureliushealthgroup.com) is a telehealth platform focused on COMPOUNDED tirzepatide MICRODOSING — a low-dose, dual GIP + GLP-1 protocol — rather than standard full-dose GLP-1 therapy. Injectable compounded tirzepatide with stackable add-ons (NAD+, L-carnitine, B12, or inositol). Pricing is published and transparent: $89 first month, then $199/month, including physician consultations, the full protocol, pharmacy shipment, monthly check-ins, secure messaging, and a HIPAA platform; cancel anytime before the next billing cycle with no hidden fees. LegitScript-certified (seal displayed; ID not captured). Notable YMYL caveat: the site itself acknowledges 'large-scale RCT data at sub-therapeutic [microdose] doses is limited' — microdosing has a thinner evidence base than the FDA-approved full-dose regimens (see our microdosing evidence reviews). No semaglutide option, no named compounding pharmacy partner, no specific state list, and no named medical director are disclosed. LOW confidence pending verification of states, pharmacy sourcing, and clinical leadership. Live-verified 2026-05-31.
Low confidence · Last verified 2026-05-31 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Aurelius Health Group is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Aurelius Health Group prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Microdose protocol (first month) | compounded | $89 |
| Microdose protocol (ongoing monthly) | compounded | $199 |
✓ Pros
- •Pricing is fully published and bundled ($89 first month / $199/mo all-in) — more transparent than many compounded-GLP-1 DTC brands
- •LegitScript-certified seal displayed
- •Care-inclusive model (consults + monthly monitoring + secure messaging) rather than transactional Rx-only
- •Unusually candid about the limited evidence base for microdosing
✗ Cons
- •MICRODOSE-only model — sub-therapeutic doses have a thinner RCT evidence base than the FDA-approved full-dose tirzepatide regimen (the site acknowledges this); expect smaller weight-loss effect than standard dosing
- •No semaglutide / standard full-dose option disclosed
- •No named compounding pharmacy partner
- •No specific state list and no named medical director / PIC disclosed
- •LegitScript ID number not captured at verification (seal present)
Ready to start with Aurelius Health Group?
Starting at $89/month. See current pricing and start your free consultation.
Sources & methodology
Our Aurelius Health Group review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 7.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to Aurelius Health Group
Belle Health
Best for: Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-oriented patients who want compounded GLP-1 alongside hormone and performance programs from a 25-year-old established brand
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Aurelius Health Group?
Starting at $89/month. See current pricing and start your free consultation.